These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9705906)

  • 21. Conservation of a proteinase cleavage site between an insect retrovirus (gypsy) Env protein and a baculovirus envelope fusion protein.
    Pearson MN; Rohrmann GF
    Virology; 2004 Apr; 322(1):61-8. PubMed ID: 15063117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques.
    Stephens EB; McCormick C; Pacyniak E; Griffin D; Pinson DM; Sun F; Nothnick W; Wong SW; Gunderson R; Berman NE; Singh DK
    Virology; 2002 Feb; 293(2):252-61. PubMed ID: 11886245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TR1.3 viral pathogenesis and syncytium formation are linked to Env-Gag cooperation.
    Murphy SL; Gaulton GN
    J Virol; 2007 Oct; 81(19):10777-85. PubMed ID: 17634219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
    Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing.
    Blair WS; Cao J; Jackson L; Jimenez J; Peng Q; Wu H; Isaacson J; Butler SL; Chu A; Graham J; Malfait AM; Tortorella M; Patick AK
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3554-61. PubMed ID: 17646410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
    Deng Y; Zheng Q; Ketas TJ; Moore JP; Lu M
    Biochemistry; 2007 Apr; 46(14):4360-9. PubMed ID: 17371053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of a modified form of CD4 results in the release of an anti-HIV factor derived from the Env sequence.
    Zaldívar I; Muñoz-Fernández MA; Alarcón B; San José E
    J Immunol; 2009 Jul; 183(2):1188-96. PubMed ID: 19553524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusion.
    Pontow SE; Heyden NV; Wei S; Ratner L
    J Virol; 2004 Jul; 78(13):7138-47. PubMed ID: 15194790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brefeldin A inhibits the processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1.
    Pal R; Mumbauer S; Hoke GM; Takatsuki A; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1991 Aug; 7(8):707-12. PubMed ID: 1718346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoproteolytic cleavage of HIV-1 gp160 envelope precursor occurs after exit from the trans-Golgi network (TGN).
    Kantanen ML; Leinikki P; Kuismanen E
    Arch Virol; 1995; 140(8):1441-9. PubMed ID: 7661695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.
    Wild C; Oas T; McDanal C; Bolognesi D; Matthews T
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10537-41. PubMed ID: 1438243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-translational modifications of the env-sea oncogene product: the role of proteolytic processing in transformation.
    Crowe AJ; Hayman MJ
    Oncogene; 1993 Jan; 8(1):181-9. PubMed ID: 8423995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein.
    Srinivas SK; Srinivas RV; Anantharamaiah GM; Segrest JP; Compans RW
    J Biol Chem; 1992 Apr; 267(10):7121-7. PubMed ID: 1551918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved antigenicity of the HIV env protein by cleavage site removal.
    Kieny MP; Lathe R; Rivière Y; Dott K; Schmitt D; Girard M; Montagnier L; Lecocq J
    Protein Eng; 1988 Sep; 2(3):219-25. PubMed ID: 3237686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of a Ca2+-independent endoprotease activity from peripheral blood lymphocytes: involvement in HIV-1 gp160 maturation.
    Bendjennat M; Bahbouhi B; Bahraoui E
    Biochemistry; 2001 Apr; 40(15):4800-10. PubMed ID: 11294648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triazine dyes inhibit HIV-1 entry by binding to envelope glycoproteins.
    Hattori T; Zhang X; Weiss C; Xu Y; Kubo T; Sato Y; Nishikawa S; Sakaida H; Uchiyama T
    Microbiol Immunol; 1997; 41(9):717-24. PubMed ID: 9343823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the R572T point mutant of a putative cleavage site in human foamy virus Env.
    Bansal A; Shaw KL; Edwards BH; Goepfert PA; Mulligan MJ
    J Virol; 2000 Mar; 74(6):2949-54. PubMed ID: 10684317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPG-NH2 acts via the metabolite alphaHGA to target HIV-1 Env to the ER-associated protein degradation pathway.
    Jejcic A; Höglund S; Vahlne A
    Retrovirology; 2010 Mar; 7():20. PubMed ID: 20230608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioorganic synthesis of end-capped anti-HIV peptides by simultaneous cyanocysteine-mediated cleavages of recombinant proteins.
    Tanaka M; Kajiwara K; Tokiwa R; Watanabe K; Ohno H; Tsutsumi H; Hata Y; Izumi K; Kodama E; Matsuoka M; Oishi S; Fujii N
    Bioorg Med Chem; 2009 Nov; 17(21):7487-92. PubMed ID: 19811922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelope protein.
    Neurath AR; Strick N; Li YY
    J Exp Med; 1992 Dec; 176(6):1561-9. PubMed ID: 1334115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.